Latest week
10 Jul 2026
Close
134.600006
Fair value
114.553048
Next-week expectancy
Positive 66.38%
Sharemaestro

NOT Chart Pack

NOVARTIS AG N

Exchange
GER
Latest week
10 Jul 2026
Close
134.600006
Fair value
114.553048
Next-week expectancy
Positive 66.38%
Generated
17 Jul 2026 04:52
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-10, NOT rose 9.48%, moving from 122.94 to 134.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 9.98 and has softened across the 12-week window. Market Dynamics is 0.25 on the latest week. Next-week expectancy is positive at 66.38% based on similar historical setup states.

Key Points

Week Ending
10 Jul 2026
Latest Close
134.60
12-Week Change
9.48%
Trend Signal
Active
Next-Week Expectancy
Positive 66.38%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
9.98
Market Dynamics
0.25

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
10 Jul 2026
Latest Close
134.60
12-Week Change
9.48%
Trend Signal
Active
Next-Week Expectancy
Positive 66.38%
Signal Weeks
12 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
9.98
Market Dynamics
0.25

Over the latest 12 completed weeks ending 2026-07-10, NOT rose 9.48%, moving from 122.94 to 134.60. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 9.98 and has softened across the 12-week window. Market Dynamics is 0.25 on the latest week. Next-week expectancy is positive at 66.38% based on similar historical setup states.

Industry Peers

Germany equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
GIS Gilead Sciences, Inc. GER 10 Jul 2026 115.02 120.80 112.54 114.86 -0.14%
PFE Pfizer Inc. GER 10 Jul 2026 21.28 21.37 20.72 21.22 -0.31%
SNW Sanofi GER 10 Jul 2026 76.55 77.11 74.43 76.12 -0.56%
BRM Bristol-Myers Squibb Company GER 10 Jul 2026 50.60 51.06 49.58 50.20 -0.79%
JNJ Johnson & Johnson GER 10 Jul 2026 229.50 235.65 225.25 226.15 -1.46%
NOV Novo Nordisk A/S GER 10 Jul 2026 43.90 44.19 42.33 43.13 -1.77%
AMG Amgen Inc. GER 10 Jul 2026 325.40 327.65 316.00 318.55 -2.11%
RHO Roche Holding AG GER 10 Jul 2026 376.40 377.40 363.60 368.00 -2.23%
LLY Eli Lilly and Company GER 10 Jul 2026 1062.80 1090.80 1036.80 1037.80 -2.35%
GS71 GSK plc GER 10 Jul 2026 23.70 23.91 22.92 22.98 -3.04%
BAYN Bayer Aktiengesellschaft GER 10 Jul 2026 53.06 53.78 49.36 50.12 -5.54%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.